위원회 위원명단 - 대한내과학회

허헐성심질환 표준진료 권고안
8. 인플루엔자 예방접종에 대한 권고 사항
2002 안정형 협심증 개정 권고안 2007 안정형 협심증 일부 개정 권고안 비고
Class I
Class I
모든 심혈관계 질환 환자들에게 인플루엔 신규*
자 예방접종은 권고된다(증거 수준: B).
References
1. McBride PE. The health consequences of smoking. Cardiovascular diseases. Med
Clin North Am 1992;76:333-53.
2. Government Printing Office. Reducing the Health Consequences of Smoking: 25
Years of Progress. Washington DC: Government Printing Office;1989.
3. Doll R, Peto R. Mortality in relation to smoking: 20 years’ observations on male British
doctors. Br Med J 1976;2:1525-36.
4. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary
heart disease among women who smoke cigarettes. N Engl J Med 1990;322:
213-7.
5. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cession
in patients with coronary heart disease: a systematic review. JAMA 2003;290:
86.
6. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP.
Echocardiographically detected left ventricular hypertrophy: prevalence and risk
factors. The Framingham Heart Study. Ann Intern Med 1988;108:7-13.
7. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various
antihypertensive therapies used as first-line agents: a network meta-analysis.
JAMA 2003;289:2534. 129. Expert Panel on Detection, Evaluation, and Treatment
of High Blood Cholesterol in Adults. Executive Summary of the Third Report of
the National Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment
Panel III). JAMA 2001; 문장 확인바랍니다
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol
in Adults. Executive Summary of the Third Report of the National Cholesterol
Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment
of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;
285:2486-97.
9. Cannon CP, Braunwald E, McCabe CH, et al. For the Pravastatin or Atorvastatin
Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators.
N Engl J Med 2004;350:1495-540.
10. Collins R, Armitage J, Parish S, Sleight P, Peto R. Heart Protection Study Collaborative
Group. Effects of cholesterol-lowering with simvastatin on stroke and other
major vascular events in 20536 people with cerebrovascular disease or other highrisk
conditions. Lancet 2004;363(9411):757-67.
11. Nissen SE, Tzucu EM, Schoenhagen P, et al. For the REVERSAL Investigators.
Effect of intensive compared with moderate lipid-lowering therapy on progression of
120